Köveker G B, Burkel W E, Graham L M, Wakefield T W, Stanley J C
Department of Surgery, University of Michigan Medical School, Ann Arbor.
J Vasc Surg. 1988 Apr;7(4):600-5.
The blood-surface interface of 12 mm ID x 5 cm ePTFE vena cava conduits, unseeded (n = 8) and seeded (n = 8) with enzymatically derived autologous endothelial cells, was studied in a canine model at 4 and 12 weeks after graft implantation. Acetylsalicylic acid (325 mg each day) and Coumadin (prothrombin time 1.4 to 1.7 times the control value) were administered preoperatively and continued 4 weeks postoperatively. Platelets labeled with 111In and 125I-labeled fibrinogen were administered 24 hours before graft removal. Luminal platelet adherence, expressed as 10(6) platelets/cm2 of graft surface, was 8.9 +/- 5.6 vs. 56.4 +/- 8.0 (p less than 0.008) and 4.0 +/- 0.9 vs. 12.4 +/- 2.3 (p less than 0.005) in seeded vs. unseeded grafts at 4 and 12 weeks, respectively. Luminal fibrinogen deposition, expressed in micrograms per square centimeter of graft surface, was 11.8 +/- 2.2 vs. 32.0 +/- 2.0 (p less than 0.06) and 6.1 +/- 2.4 vs. 12.4 +/- 6.3 (p less than 0.005) in seeded vs. unseeded grafts at 4 and 12 weeks, respectively. Cumulative 4- and 12-week luminal production of 6-keto-PGF1 alpha from seeded and unseeded grafts represented 11% and 5%, respectively, of that produced from the native iliac vein. Luminal endothelial cell coverage was 71% +/- 22% vs. 33% +/- 9% and 79% +/- 8% vs. 55% +/- 8% (p less than 0.05) in seeded and unseeded grafts at 4 and 12 weeks, respectively. Although endothelialization was not complete in seeded vena cava grafts, it is clear that seeded prostheses exhibited improved thromboresistance compared with unseeded conduits.
在犬类模型中,对内径12毫米、长5厘米、未接种(n = 8)和接种(n = 8)酶解自体内皮细胞的ePTFE腔静脉导管的血液-表面界面进行了研究,观察时间为移植后4周和12周。术前给予乙酰水杨酸(每日325毫克)和香豆素(凝血酶原时间为对照值的1.4至1.7倍),并持续至术后4周。在移除移植物前24小时注射用111In标记的血小板和125I标记的纤维蛋白原。以每平方厘米移植物表面的10(6)个血小板表示的腔内血小板粘附,在接种和未接种的移植物中,4周时分别为8.9±5.6对56.4±8.0(p<0.008),12周时分别为4.0±0.9对12.4±2.3(p<0.005)。以每平方厘米移植物表面的微克数表示的腔内纤维蛋白原沉积,在接种和未接种的移植物中,4周时分别为11.8±2.2对32.0±2.0(p<0.06),12周时分别为6.1±2.4对12.4±6.3(p<0.005)。接种和未接种移植物4周和12周腔内6-酮-PGF1α的累积生成量分别占髂内静脉生成量的11%和5%。接种和未接种移植物在4周和12周时的腔内内皮细胞覆盖率分别为71%±22%对33%±9%和79%±8%对55%±8%(p<0.05)。虽然接种的腔静脉移植物内皮化不完全,但显然接种的假体与未接种的导管相比,血栓抵抗性有所改善。